Compare CWBC & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWBC | BVS |
|---|---|---|
| Founded | 1989 | 2011 |
| Country | United States | United States |
| Employees | 341 | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 644.3M | 617.1M |
| IPO Year | N/A | 2016 |
| Metric | CWBC | BVS |
|---|---|---|
| Price | $24.14 | $10.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $28.63 | $14.00 |
| AVG Volume (30 Days) | 202.3K | ★ 408.4K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.03% | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $39.58 | $7.52 |
| Revenue Next Year | $17.64 | $7.06 |
| P/E Ratio | ★ $12.13 | $32.36 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.50 | $5.81 |
| 52 Week High | $25.72 | $10.76 |
| Indicator | CWBC | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 56.93 | 69.29 |
| Support Level | $22.02 | $8.27 |
| Resistance Level | $24.34 | N/A |
| Average True Range (ATR) | 0.47 | 0.50 |
| MACD | -0.05 | 0.05 |
| Stochastic Oscillator | 48.03 | 84.36 |
Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments. The company has one reportable segment: Banking operations. Loans and leases, investment securities, interest-bearing deposits and non-interest income provide the revenues of the banking operation.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.